0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nausea And Vomiting Treatment Market Insights, Forecast to 2030
Published Date: July 2024
|
Report Code: QYRE-Auto-32P7025
Home | Market Reports | Health| Reproductive Health
China Nausea And Vomiting Treatment Market Report Forecast 2021 2027
BUY CHAPTERS

Global Nausea And Vomiting Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-32P7025
Report
July 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nausea And Vomiting Treatment Market Size

The global Nausea And Vomiting Treatment market is projected to grow from US$ 5561.9 million in 2024 to US$ 8115.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.

Nausea And Vomiting Treatment Market

Nausea And Vomiting Treatment Market

Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.
Market Analysis and Insights: Global Nausea And Vomiting Treatment Market
United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.Merck & Co. Inc. was the global greatest company in Nausea And Vomiting Treatment industry, with the market Share of 14% , followed by Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.
Report Covers:
This report presents an overview of global market for Nausea And Vomiting Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Nausea And Vomiting Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Nausea And Vomiting Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nausea And Vomiting Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Nausea And Vomiting Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Nausea And Vomiting Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Nausea And Vomiting Treatment Market Report

Report Metric Details
Report Name Nausea And Vomiting Treatment Market
Accounted market size in 2024 US$ 5561.9 million
Forecasted market size in 2030 US$ 8115.6 million
CAGR 6.5
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • Serotonin Receptor Antagonist
  • Neurokinin NK1 Receptor Antagonist
  • Others
Segment by Application
  • CINV
  • PONV
  • Motion Sickness
  • Pregnancy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck & Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Pharmanovia, Mylan, Duchesnay, GSK
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Nausea And Vomiting Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Nausea And Vomiting Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nausea And Vomiting Treatment revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Nausea And Vomiting Treatment Market growing?

Ans: The Nausea And Vomiting Treatment Market witnessing a CAGR of 6.5 during the forecast period 2024-2030.

What is the Nausea And Vomiting Treatment Market size in 2030?

Ans: The Nausea And Vomiting Treatment Market size in 2030 will be US$ 8115.6 million.

What is the Nausea And Vomiting Treatment Market share by region?

Ans: United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.

Who are the main players in the Nausea And Vomiting Treatment Market report?

Ans: The main players in the Nausea And Vomiting Treatment Market are Merck & Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Pharmanovia, Mylan, Duchesnay, GSK

What are the Application segmentation covered in the Nausea And Vomiting Treatment Market report?

Ans: The Applications covered in the Nausea And Vomiting Treatment Market report are CINV, PONV, Motion Sickness, Pregnancy, Others

What are the Type segmentation covered in the Nausea And Vomiting Treatment Market report?

Ans: The Types covered in the Nausea And Vomiting Treatment Market report are Serotonin Receptor Antagonist, Neurokinin NK1 Receptor Antagonist, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Serotonin Receptor Antagonist
1.2.3 Neurokinin NK1 Receptor Antagonist
1.2.4 Others
1.3 Market by Application
1.3.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 CINV
1.3.3 PONV
1.3.4 Motion Sickness
1.3.5 Pregnancy
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nausea And Vomiting Treatment Market Perspective (2019-2030)
2.2 Global Nausea And Vomiting Treatment Growth Trends by Region
2.2.1 Nausea And Vomiting Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nausea And Vomiting Treatment Historic Market Size by Region (2019-2024)
2.2.3 Nausea And Vomiting Treatment Forecasted Market Size by Region (2025-2030)
2.3 Nausea And Vomiting Treatment Market Dynamics
2.3.1 Nausea And Vomiting Treatment Industry Trends
2.3.2 Nausea And Vomiting Treatment Market Drivers
2.3.3 Nausea And Vomiting Treatment Market Challenges
2.3.4 Nausea And Vomiting Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Nausea And Vomiting Treatment by Players
3.1.1 Global Nausea And Vomiting Treatment Revenue by Players (2019-2024)
3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Nausea And Vomiting Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Nausea And Vomiting Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Nausea And Vomiting Treatment Market Concentration Ratio
3.4.1 Global Nausea And Vomiting Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nausea And Vomiting Treatment Revenue in 2023
3.5 Global Key Players of Nausea And Vomiting Treatment Head office and Area Served
3.6 Global Key Players of Nausea And Vomiting Treatment, Product and Application
3.7 Global Key Players of Nausea And Vomiting Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nausea And Vomiting Treatment Breakdown Data by Type
4.1 Global Nausea And Vomiting Treatment Historic Market Size by Type (2019-2024)
4.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2025-2030)
5 Nausea And Vomiting Treatment Breakdown Data by Application
5.1 Global Nausea And Vomiting Treatment Historic Market Size by Application (2019-2024)
5.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nausea And Vomiting Treatment Market Size (2019-2030)
6.2 North America Nausea And Vomiting Treatment Market Size by Type
6.2.1 North America Nausea And Vomiting Treatment Market Size by Type (2019-2024)
6.2.2 North America Nausea And Vomiting Treatment Market Size by Type (2025-2030)
6.2.3 North America Nausea And Vomiting Treatment Market Share by Type (2019-2030)
6.3 North America Nausea And Vomiting Treatment Market Size by Application
6.3.1 North America Nausea And Vomiting Treatment Market Size by Application (2019-2024)
6.3.2 North America Nausea And Vomiting Treatment Market Size by Application (2025-2030)
6.3.3 North America Nausea And Vomiting Treatment Market Share by Application (2019-2030)
6.4 North America Nausea And Vomiting Treatment Market Size by Country
6.4.1 North America Nausea And Vomiting Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Nausea And Vomiting Treatment Market Size by Country (2019-2024)
6.4.3 North America Nausea And Vomiting Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Nausea And Vomiting Treatment Market Size (2019-2030)
7.2 Europe Nausea And Vomiting Treatment Market Size by Type
7.2.1 Europe Nausea And Vomiting Treatment Market Size by Type (2019-2024)
7.2.2 Europe Nausea And Vomiting Treatment Market Size by Type (2025-2030)
7.2.3 Europe Nausea And Vomiting Treatment Market Share by Type (2019-2030)
7.3 Europe Nausea And Vomiting Treatment Market Size by Application
7.3.1 Europe Nausea And Vomiting Treatment Market Size by Application (2019-2024)
7.3.2 Europe Nausea And Vomiting Treatment Market Size by Application (2025-2030)
7.3.3 Europe Nausea And Vomiting Treatment Market Share by Application (2019-2030)
7.4 Europe Nausea And Vomiting Treatment Market Size by Country
7.4.1 Europe Nausea And Vomiting Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Nausea And Vomiting Treatment Market Size by Country (2019-2024)
7.4.3 Europe Nausea And Vomiting Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Nausea And Vomiting Treatment Market Size (2019-2030)
8.2 China Nausea And Vomiting Treatment Market Size by Type
8.2.1 China Nausea And Vomiting Treatment Market Size by Type (2019-2024)
8.2.2 China Nausea And Vomiting Treatment Market Size by Type (2025-2030)
8.2.3 China Nausea And Vomiting Treatment Market Share by Type (2019-2030)
8.3 China Nausea And Vomiting Treatment Market Size by Application
8.3.1 China Nausea And Vomiting Treatment Market Size by Application (2019-2024)
8.3.2 China Nausea And Vomiting Treatment Market Size by Application (2025-2030)
8.3.3 China Nausea And Vomiting Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Nausea And Vomiting Treatment Market Size (2019-2030)
9.2 Asia Nausea And Vomiting Treatment Market Size by Type
9.2.1 Asia Nausea And Vomiting Treatment Market Size by Type (2019-2024)
9.2.2 Asia Nausea And Vomiting Treatment Market Size by Type (2025-2030)
9.2.3 Asia Nausea And Vomiting Treatment Market Share by Type (2019-2030)
9.3 Asia Nausea And Vomiting Treatment Market Size by Application
9.3.1 Asia Nausea And Vomiting Treatment Market Size by Application (2019-2024)
9.3.2 Asia Nausea And Vomiting Treatment Market Size by Application (2025-2030)
9.3.3 Asia Nausea And Vomiting Treatment Market Share by Application (2019-2030)
9.4 Asia Nausea And Vomiting Treatment Market Size by Region
9.4.1 Asia Nausea And Vomiting Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Nausea And Vomiting Treatment Market Size by Region (2019-2024)
9.4.3 Asia Nausea And Vomiting Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck & Co. Inc.
11.1.1 Merck & Co. Inc. Company Details
11.1.2 Merck & Co. Inc. Business Overview
11.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Introduction
11.1.4 Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.1.5 Merck & Co. Inc. Recent Developments
11.2 Helsinn Group
11.2.1 Helsinn Group Company Details
11.2.2 Helsinn Group Business Overview
11.2.3 Helsinn Group Nausea And Vomiting Treatment Introduction
11.2.4 Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.2.5 Helsinn Group Recent Developments
11.3 Unimed Pharmaceuticals (AbbVie Inc.)
11.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Details
11.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
11.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Introduction
11.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Developments
11.4 Kyowa Kirin
11.4.1 Kyowa Kirin Company Details
11.4.2 Kyowa Kirin Business Overview
11.4.3 Kyowa Kirin Nausea And Vomiting Treatment Introduction
11.4.4 Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.4.5 Kyowa Kirin Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Nausea And Vomiting Treatment Introduction
11.5.4 Sanofi Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.5.5 Sanofi Recent Developments
11.6 Qilu Pharma
11.6.1 Qilu Pharma Company Details
11.6.2 Qilu Pharma Business Overview
11.6.3 Qilu Pharma Nausea And Vomiting Treatment Introduction
11.6.4 Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.6.5 Qilu Pharma Recent Developments
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Details
11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Introduction
11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.8 Taiji group
11.8.1 Taiji group Company Details
11.8.2 Taiji group Business Overview
11.8.3 Taiji group Nausea And Vomiting Treatment Introduction
11.8.4 Taiji group Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.8.5 Taiji group Recent Developments
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Nausea And Vomiting Treatment Introduction
11.9.4 Novartis Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.9.5 Novartis Recent Developments
11.10 Heron Therapeutics
11.10.1 Heron Therapeutics Company Details
11.10.2 Heron Therapeutics Business Overview
11.10.3 Heron Therapeutics Nausea And Vomiting Treatment Introduction
11.10.4 Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.10.5 Heron Therapeutics Recent Developments
11.11 Pharmanovia
11.11.1 Pharmanovia Company Details
11.11.2 Pharmanovia Business Overview
11.11.3 Pharmanovia Nausea And Vomiting Treatment Introduction
11.11.4 Pharmanovia Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.11.5 Pharmanovia Recent Developments
11.12 Mylan
11.12.1 Mylan Company Details
11.12.2 Mylan Business Overview
11.12.3 Mylan Nausea And Vomiting Treatment Introduction
11.12.4 Mylan Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.12.5 Mylan Recent Developments
11.13 Duchesnay
11.13.1 Duchesnay Company Details
11.13.2 Duchesnay Business Overview
11.13.3 Duchesnay Nausea And Vomiting Treatment Introduction
11.13.4 Duchesnay Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.13.5 Duchesnay Recent Developments
11.14 GSK
11.14.1 GSK Company Details
11.14.2 GSK Business Overview
11.14.3 GSK Nausea And Vomiting Treatment Introduction
11.14.4 GSK Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.14.5 GSK Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Nausea And Vomiting Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Serotonin Receptor Antagonist
    Table 3. Key Players of Neurokinin NK1 Receptor Antagonist
    Table 4. Key Players of Others
    Table 5. Global Nausea And Vomiting Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Nausea And Vomiting Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Nausea And Vomiting Treatment Market Share by Region (2019-2024)
    Table 9. Global Nausea And Vomiting Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Nausea And Vomiting Treatment Market Share by Region (2025-2030)
    Table 11. Nausea And Vomiting Treatment Market Trends
    Table 12. Nausea And Vomiting Treatment Market Drivers
    Table 13. Nausea And Vomiting Treatment Market Challenges
    Table 14. Nausea And Vomiting Treatment Market Restraints
    Table 15. Global Nausea And Vomiting Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Nausea And Vomiting Treatment Revenue Share by Players (2019-2024)
    Table 17. Global Top Nausea And Vomiting Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nausea And Vomiting Treatment as of 2023)
    Table 18. Global Nausea And Vomiting Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Nausea And Vomiting Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Nausea And Vomiting Treatment, Headquarters and Area Served
    Table 21. Global Key Players of Nausea And Vomiting Treatment, Product and Application
    Table 22. Global Key Players of Nausea And Vomiting Treatment, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Nausea And Vomiting Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2019-2024)
    Table 26. Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2025-2030)
    Table 28. Global Nausea And Vomiting Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Nausea And Vomiting Treatment Revenue Share by Application (2019-2024)
    Table 30. Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Nausea And Vomiting Treatment Revenue Share by Application (2025-2030)
    Table 32. North America Nausea And Vomiting Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Nausea And Vomiting Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Nausea And Vomiting Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Nausea And Vomiting Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Nausea And Vomiting Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Nausea And Vomiting Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Nausea And Vomiting Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Nausea And Vomiting Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Nausea And Vomiting Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Nausea And Vomiting Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Nausea And Vomiting Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Nausea And Vomiting Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Nausea And Vomiting Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Nausea And Vomiting Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Nausea And Vomiting Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Nausea And Vomiting Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Nausea And Vomiting Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Nausea And Vomiting Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Nausea And Vomiting Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Nausea And Vomiting Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Nausea And Vomiting Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Nausea And Vomiting Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Nausea And Vomiting Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Nausea And Vomiting Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Nausea And Vomiting Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Nausea And Vomiting Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Merck & Co. Inc. Company Details
    Table 65. Merck & Co. Inc. Business Overview
    Table 66. Merck & Co. Inc. Nausea And Vomiting Treatment Product
    Table 67. Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 68. Merck & Co. Inc. Recent Developments
    Table 69. Helsinn Group Company Details
    Table 70. Helsinn Group Business Overview
    Table 71. Helsinn Group Nausea And Vomiting Treatment Product
    Table 72. Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 73. Helsinn Group Recent Developments
    Table 74. Unimed Pharmaceuticals (AbbVie Inc.) Company Details
    Table 75. Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
    Table 76. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product
    Table 77. Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 78. Unimed Pharmaceuticals (AbbVie Inc.) Recent Developments
    Table 79. Kyowa Kirin Company Details
    Table 80. Kyowa Kirin Business Overview
    Table 81. Kyowa Kirin Nausea And Vomiting Treatment Product
    Table 82. Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 83. Kyowa Kirin Recent Developments
    Table 84. Sanofi Company Details
    Table 85. Sanofi Business Overview
    Table 86. Sanofi Nausea And Vomiting Treatment Product
    Table 87. Sanofi Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 88. Sanofi Recent Developments
    Table 89. Qilu Pharma Company Details
    Table 90. Qilu Pharma Business Overview
    Table 91. Qilu Pharma Nausea And Vomiting Treatment Product
    Table 92. Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 93. Qilu Pharma Recent Developments
    Table 94. Teva Pharmaceutical Industries Ltd. Company Details
    Table 95. Teva Pharmaceutical Industries Ltd. Business Overview
    Table 96. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product
    Table 97. Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 98. Teva Pharmaceutical Industries Ltd. Recent Developments
    Table 99. Taiji group Company Details
    Table 100. Taiji group Business Overview
    Table 101. Taiji group Nausea And Vomiting Treatment Product
    Table 102. Taiji group Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 103. Taiji group Recent Developments
    Table 104. Novartis Company Details
    Table 105. Novartis Business Overview
    Table 106. Novartis Nausea And Vomiting Treatment Product
    Table 107. Novartis Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 108. Novartis Recent Developments
    Table 109. Heron Therapeutics Company Details
    Table 110. Heron Therapeutics Business Overview
    Table 111. Heron Therapeutics Nausea And Vomiting Treatment Product
    Table 112. Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 113. Heron Therapeutics Recent Developments
    Table 114. Pharmanovia Company Details
    Table 115. Pharmanovia Business Overview
    Table 116. Pharmanovia Nausea And Vomiting Treatment Product
    Table 117. Pharmanovia Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 118. Pharmanovia Recent Developments
    Table 119. Mylan Company Details
    Table 120. Mylan Business Overview
    Table 121. Mylan Nausea And Vomiting Treatment Product
    Table 122. Mylan Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 123. Mylan Recent Developments
    Table 124. Duchesnay Company Details
    Table 125. Duchesnay Business Overview
    Table 126. Duchesnay Nausea And Vomiting Treatment Product
    Table 127. Duchesnay Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 128. Duchesnay Recent Developments
    Table 129. GSK Company Details
    Table 130. GSK Business Overview
    Table 131. GSK Nausea And Vomiting Treatment Product
    Table 132. GSK Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 133. GSK Recent Developments
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Nausea And Vomiting Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Nausea And Vomiting Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Serotonin Receptor Antagonist Features
    Figure 4. Neurokinin NK1 Receptor Antagonist Features
    Figure 5. Others Features
    Figure 6. Global Nausea And Vomiting Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Nausea And Vomiting Treatment Market Share by Application: 2023 VS 2030
    Figure 8. CINV Case Studies
    Figure 9. PONV Case Studies
    Figure 10. Motion Sickness Case Studies
    Figure 11. Pregnancy Case Studies
    Figure 12. Others Case Studies
    Figure 13. Nausea And Vomiting Treatment Report Years Considered
    Figure 14. Global Nausea And Vomiting Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Nausea And Vomiting Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Nausea And Vomiting Treatment Market Share by Region: 2023 VS 2030
    Figure 17. Global Nausea And Vomiting Treatment Market Share by Players in 2023
    Figure 18. Global Top Nausea And Vomiting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nausea And Vomiting Treatment as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Nausea And Vomiting Treatment Revenue in 2023
    Figure 20. North America Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Nausea And Vomiting Treatment Market Share by Type (2019-2030)
    Figure 22. North America Nausea And Vomiting Treatment Market Share by Application (2019-2030)
    Figure 23. North America Nausea And Vomiting Treatment Market Share by Country (2019-2030)
    Figure 24. United States Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Nausea And Vomiting Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Nausea And Vomiting Treatment Market Share by Type (2019-2030)
    Figure 28. Europe Nausea And Vomiting Treatment Market Share by Application (2019-2030)
    Figure 29. Europe Nausea And Vomiting Treatment Market Share by Country (2019-2030)
    Figure 30. Germany Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Nausea And Vomiting Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Nausea And Vomiting Treatment Market Share by Type (2019-2030)
    Figure 38. China Nausea And Vomiting Treatment Market Share by Application (2019-2030)
    Figure 39. Asia Nausea And Vomiting Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Nausea And Vomiting Treatment Market Share by Type (2019-2030)
    Figure 41. Asia Nausea And Vomiting Treatment Market Share by Application (2019-2030)
    Figure 42. Asia Nausea And Vomiting Treatment Market Share by Region (2019-2030)
    Figure 43. Japan Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Nausea And Vomiting Treatment Market Share by Country (2019-2030)
    Figure 53. Brazil Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Merck & Co. Inc. Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 60. Helsinn Group Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 61. Unimed Pharmaceuticals (AbbVie Inc.) Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 62. Kyowa Kirin Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 63. Sanofi Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 64. Qilu Pharma Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 65. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 66. Taiji group Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 67. Novartis Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 68. Heron Therapeutics Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 69. Pharmanovia Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 70. Mylan Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 71. Duchesnay Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 72. GSK Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS